Effect of pentoxifylline on hepatic ischemia and reperfusion injury

Surgery

Volumn 121, Issue 5, 1997, Pages 520-525

  Fabia, Renata ^a   Travis, Denise L ^a   Levy, Marion F ^a   Husberg, Bo S ^a   Goldstein, Robert M ^a   Klintmalm, Goran B ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENTOXIFYLLINE;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LIVER INJURY; LIVER ISCHEMIA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REPERFUSION INJURY; SURVIVAL; SWINE;

EID: 0030911259     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90106-9     Document Type: Article

References (26)

1. Breuillé D, Farge MC, Rosé F, Arnal M, Attaix D. Obled C. Pentoxifylline decreases body weight loss and muscle protein wasting characteristics of sepsis. Am J Physiol 1993;265:E660-6.
2. Flynn WJ, Cryer HG, Garrison RN. Pentoxifylline restores intestinal microvascular blood flow during resuscitated hemorrhagic shock. Surgery 1991;110:350-6.
3. Peng X-X, Currin RT, Thurman RG, Lemasters JJ. Protection by pentoxifylline against normothermic liver ischemia/reperfusion in rats. Transplantation 1995;59:1537-41.
4. Wang P, Ba ZF, Zhou M, Tait SM, Chaudry IH. Pentoxifylline restores cardiac output and tissue perfusion after trauma-hemorrhage and decreases susceptibility to sepsis. Surgery 1993;114:352-9.
5. Oshima N, Ibaraki MS. Effect of pentoxifylline on microvascular blood flow velocity. Angiology 1981;32:752-63.
6. Schroer RH. Antithrombotic potential of pentoxifylline. a hernorheologically active drug. Angiology 1985;36:387-93.
7. Adams JG Jr, Dhar A, Shivendra DS, Shukla SD, Silver D. Effect of pentoxifylline on tissue injury and platelet-activating factor producdon during ischemia-reperfusion injury. J Vasc Surg 1995;21:742-9.
8. Wang P, Ba ZF. Morrison MH, Ayala A, Chaudry IH. Mechanism of the beneficial effects of pentoxifylline on hepatocellular function after trauma hemorrhage and resuscitation. Surgery 1992;112:451-8.
9. Mandfil G. ARDS, neutrophils and pentoxifylline. Am Rev Respir Dis 1988;138:1103-5.
10. Kozaki K. Egawa L, Bermudas L, Feduska NJ. So S, Esquivel CO. Pentoxifylline inhibits production of Superoxide anion and tumor necrosis factor by Kupffer cells in rat liver preservation. Transplant Proc 1993;25:3205-6.
11. Waxman K. Holness R, Tominaga G, Oslund S, Pinderski L, Soliman MH. Pentoxifylline improves tissue oxygenation after hemorrhagic shock. Surgery 1987;102:358-61.
12. Bachmann S, Caldwell-Kenkel JC. Currin RT, et al. Protection by pentoxifylline against graft failure from storage injury after orthotopic rat liver transplantation with arterializadon. Transpl Int 1992;5(suppl 1):S345-50.
13. Clavien PA. Harvey PR, Strasberg SM. Preservation and reperfusion injuries and liver allografts: an overview and synthesis of current studies. Transplantation 1992;53:957-78.
14. Bachmann C, Caldwell-Kenkel JC, Currin RT, Tanaka Y, Takei Y. Marzi I, et al. Ultrastructural correlates of liver graft failure from storage injury: studies of graft protection by Carolina rinse solution and pentoxifylline. Transplant Proc 1993;25:1620-4.
15. Kim YI. Kawano K, Nakashima K, Goto S, Kobayshi M. Alleviation of 3.5-hour warm ischemic injury of liver in pigs by cyclosporine pretherapy. Transplantation 1991;51:731-3.
16. Nishiyama R, Nakamura S, Suzuki S, Baba S. Platelet-activating factor in hepatic ischemia/reperfusion injury. Transplantation 1993;55:1261-5.
17. Helling TS, Hacker KA, Kragel PJ, Eisenstein CL. Evidence for cytoprotection by prostaglandin El with normothermic hepatic ischemia. J Surg Res 1994:56:309-13.
18. Swindle MM. Porcine models in surgical research: an overview. In: Tumbleson M, editor. Swine in biomedical research, vol. 1. New York: Plenum Press, 1986:235-42.
19. Barosso AJ. Schmid-Schonbein GW. Pentoxifylline pretreatment decreases the pool of circulaung activated neutrophils. in vivo adhesion to endothelium, and improves survival from hemorrhagic shock. Biorheology 1990;27:401-18.
20. Okabayashi K, Aoe M, DeMeester SR, Cooper JD, Patterson GA. Pentoxifylline reduces lung allograft reperfusion injury. Ann Thorac Surg 1994;58:50-6.
21. Samalska CP, Winfield EA. Pentoxifylline. J Am Acad Dermatol 1994;30:603-21.
22. Ward A. Clissold SP. Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987;34:50-97.
23. Duncan JR, Prasse KW. Hepadc laboratory tests. In: Veterinary laboratory medicine clinical pathology. Ames, Iowa: State University Press. 1986:123-7.
24. Kumar V, Cotran RS, Robbins SL. Acute and chronic inflammation. In: Basic pathology. Philadelphia: WB Saunders Company, 1992:25-46.
25. Flvnn WJ, Cryer HG. Garrison RN. Pentoxifylline but not saralasin restores blood flow after resuscitation from hemorrhagic shock. J Surg Res 1991;50:616-21.
26. Allegra C, Carlizza A, Mari A. Long-term infusional and oral therapy with pentoxifylline in peripheral vasculopathy: a 3-year follow-up. Clinical Hemorheology 1994:14:413-8.